Friday, February 26, 2021 6:28:28 PM
PT= $30-40 (by or around March 31st)
https://msmoneymoves.com/2021/02/17/knsa-report/
https://msmoneymoves.com/2021/02/17/knsa-report/
Recent KNSA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:54:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2026 08:45:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:34:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/28/2026 08:16:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:32:20 AM
- Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution • GlobeNewswire Inc. • 04/28/2026 11:30:00 AM
- Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 • GlobeNewswire Inc. • 04/23/2026 08:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/16/2026 08:34:49 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 08:33:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 08:32:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 08:34:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/09/2026 08:03:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:45:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:44:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:41:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:39:43 PM
- Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/06/2026 08:04:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:41:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:40:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:37:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:35:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/09/2026 09:24:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:40:56 PM
